$SNDY has resumed sales of its MammoView® Ductoscopy Instruments as a result of its ability to fulfill all of its backorders, which were due to production issues experienced from one of its component manufacturers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.